Research and development - Press Releases

Date	Title	Company
25-Nov-2022	Alfa Chemistry Shows Expertise in Customized Design and Synthesis of Silazanes	Alfa Chemistry
24-Nov-2022	Allero Therapeutics Receives EIC Horizon Grant to Advance Treatment of Celiac Disease	Allero Therapeutics
23-Nov-2022	HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer	HpVac SA
22-Nov-2022	Copley Scientific named Nottinghamshire Business of the Year	Copley Scientific
22-Nov-2022	Quell Therapeutics to Present at Upcoming Investor Conferences in 2022	Quell Therapeutics
22-Nov-2022	HEMOPHILIA TREATMENT: NEW INSIGHTS CONTRIBUTE TO MINIMIZE OR ELIMINATE SIDE EFFECTS IN THE FUTURE	Institute Krems Bioanalytics of IMC Krems and Takeda
22-Nov-2022	BOC Sciences Continues to Power Up RNA Therapeutics with siRNA Products and Services	BOC Sciences
22-Nov-2022	Hemophilia Treatment: New Insights Contribute to Minimize or Eliminate Side Effects in the Future	IMC Krems University of Applied Sciences
22-Nov-2022	Turbine raises €20m for AI platform to deliver targeted cancer treatments	Turbine
22-Nov-2022	The Cell and Gene Therapy Catapult marks ten years of ground-breaking collaborations and progress in the UK cell and gene therapy industry	The Cell and Gene Therapy Catapult
22-Nov-2022	OSE Immunotherapeutics Announces Publication of Peer-Reviewed Data on CLEC-1, its Novel Myeloid Immune Checkpoint in ‘Science Advances’	OSE Immunotherapeutics
21-Nov-2022	PerkinElmer Helps Accelerate Gene Therapy Research with Industry-First Ready-to-Use Viral Vector Assays	PerkinElmer, Inc.
21-Nov-2022	EDX Medical Group Plc announces European Cancer Biomarker Programme collaboration with Tianjin Bioscience Diagnostic Technology Co. Ltd	EDX Medical Group Plc
21-Nov-2022	Quell Therapeutics Appoints Luke Devey, BMBCh, Ph.D. as Chief Medical Officer	Quell Therapeutics
15-Nov-2022	Researchers make miniature ‘bone marrows in a dish’ to improve anti-cancer treatments	University of Birmingham
15-Nov-2022	Edmund Optics© Announces 2022 Educational Award and Norman Edmund Award Recipients	Edmund Optics©
15-Nov-2022	Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)	Boditech Med and SphingoTec
15-Nov-2022	First completion of a full treatment workflow in the first European hospital-based BNCT facility	Neutron Therapeutics
15-Nov-2022	Precision Medicine Spend to Exceed $132 Billion Globally by 2027; Driven by Efficiency Gains for Healthcare Providers	Juniper Research
15-Nov-2022	ImmunOs Therapeutics´ Lead Program Shows Strong Anti-Tumor Activity In Vivo and In Vitro	ImmunOs Therapeutics